Stocks News

LAST PRICE
234.8800
TODAY'S CHANGE (%)
Trending Up0.9000 (0.3846%)

Bid / Lots
170.0000/ 1
Ask / Lots
250.1000/ 1
Open / Previous Close
233.1000 / 233.9800
Day Range
Low 233.1000
High 236.9300
52 Week Range
Low 167.4200
High 261.7300
Volume
697,640
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Apr 23, 2024
- IQVIA Celebrates Wendy Stewart and Susan Barnes, Winners of Healthcare Businesswoman's Association Luminary and Rising Star Awards, from 9:00AM ET on Tuesday Apr 23, 2024 by Dow Jones
  9:00AM ET on Tuesday Apr 23, 2024 by Dow Jones
  Companies Mentioned: IQV
  RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--April 23, 2024--
  IQVIA (NYSE:IQV) today announced that Wendy Stewart, president of Clinical Operations at IQVIA, and Susan Barnes, senior director of IQVIA Biotech Strategic Operations, have been honored with the Healthcare Businesswoman's Association Luminary and Rising Star Awards, respectively.
Apr 22, 2024
- --Mizuho Securities Adjusts IQVIA Holdings' Price Target to $277 From $268, Maintains Buy Rating, from 6:23AM ET on Monday Apr 22, 2024 by MT Newswires
  6:23AM ET on Monday Apr 22, 2024 by MT Newswires
  Companies Mentioned: IQV
  06:23 AM EDT, 04/22/2024 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contac...
Apr 15, 2024
- Press Release: IQVIA to Announce First-Quarter 2024 Results on May 2, 2024, from 4:20PM ET on Monday Apr 15, 2024 by Dow Jones
  4:20PM ET on Monday Apr 15, 2024 by Dow Jones
  Companies Mentioned: IQV
  
  IQVIA to Announce First-Quarter 2024 Results on May 2, 2024
  RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--April 15, 2024--
  IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) will announce its first-quarter 2024 financial results before the market opens on Thursday, May 2, 2024. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com.
- IQVIA to Announce First-Quarter 2024 Results on May 2, 2024, from 4:15PM ET on Monday Apr 15, 2024 by Dow Jones
  4:15PM ET on Monday Apr 15, 2024 by Dow Jones
  Companies Mentioned: IQV
  RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--April 15, 2024--
  IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) will announce its first-quarter 2024 financial results before the market opens on Thursday, May 2, 2024. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com.
Apr 8, 2024
- Iqvia, Salesforce Collaborate to Accelerate Life Sciences Cloud Development, from 4:41PM ET on Monday Apr 08, 2024 by MT Newswires
  4:41PM ET on Monday Apr 08, 2024 by MT Newswires
  Companies Mentioned: IQV, CRM
  04:41 PM EDT, 04/08/2024 (MT Newswires) -- Iqvia Holdings (IQV) and Salesforce (CRM) said Monday they will combine their capabilities in data, artificial intelligence and technology to develop an advanced customer engagement platform for the global ...

Today
- Regeneron Faces Q1 Seasonality Despite Eylea HD Launch, Oppenheimer Says, from 4 hours ago by MT Newswires
  4 hours ago by MT Newswires
  Companies Mentioned: REGN
- Guggenheim Adjusts Price Target on Biogen to $255 From $275, from 5 hours ago by MT Newswires
  5 hours ago by MT Newswires
  Companies Mentioned: BIIB
- --UBS Adjusts ICON Price Target to $380 From $368, Maintains Buy Rating, from 6 hours ago by MT Newswires
  6 hours ago by MT Newswires
  Companies Mentioned: ICLR
- Oppenheimer Adjusts Price Target on Regeneron Pharmaceuticals to $1,175 From $1,125, from 8 hours ago by MT Newswires
  8 hours ago by MT Newswires
  Companies Mentioned: REGN
Yesterday
- --Goldman Sachs Adjusts Biogen Price Target to $340 From $393, from 8:18AM ET on Thursday Apr 25, 2024 by MT Newswires
  8:18AM ET on Thursday Apr 25, 2024 by MT Newswires
  Companies Mentioned: BIIB
- --Canaccord Genuity Adjusts Price Target on Biogen to $308 From $305, from 8:03AM ET on Thursday Apr 25, 2024 by MT Newswires
  8:03AM ET on Thursday Apr 25, 2024 by MT Newswires
  Companies Mentioned: BIIB
- --Barclays Adjusts Price Target on Biogen to $200 From $215, from 8:02AM ET on Thursday Apr 25, 2024 by MT Newswires
  8:02AM ET on Thursday Apr 25, 2024 by MT Newswires
  Companies Mentioned: BIIB
- --HC Wainwright Adjusts Biogen's Price Target to $300 From $325, from 7:39AM ET on Thursday Apr 25, 2024 by MT Newswires
  7:39AM ET on Thursday Apr 25, 2024 by MT Newswires
  Companies Mentioned: BIIB
- --Wedbush Adjusts Price Target on Biogen to $215 From $213, from 6:48AM ET on Thursday Apr 25, 2024 by MT Newswires
  6:48AM ET on Thursday Apr 25, 2024 by MT Newswires
  Companies Mentioned: BIIB
Apr 24, 2024
- ICON Q1 Adjusted EPS, Revenue Rise, 2024 Guidance Range Narrowed, from 4:55PM ET on Wednesday Apr 24, 2024 by MT Newswires
  4:55PM ET on Wednesday Apr 24, 2024 by MT Newswires
  Companies Mentioned: ICLR

IQVIA Holdings Inc
NYSE:IQVUnited States

Search Criteria

Apr 23, 2024

IQVIA Celebrates Wendy Stewart and Susan Barnes, Winners of Healthcare Businesswoman's Association Luminary and Rising Star Awards, from 9:00AM ET on Tuesday Apr 23, 2024 by Dow Jones

Apr 22, 2024

--Mizuho Securities Adjusts IQVIA Holdings' Price Target to $277 From $268, Maintains Buy Rating, from 6:23AM ET on Monday Apr 22, 2024 by MT Newswires

Apr 15, 2024

Press Release: IQVIA to Announce First-Quarter 2024 Results on May 2, 2024, from 4:20PM ET on Monday Apr 15, 2024 by Dow Jones

IQVIA to Announce First-Quarter 2024 Results on May 2, 2024, from 4:15PM ET on Monday Apr 15, 2024 by Dow Jones

Apr 8, 2024

Iqvia, Salesforce Collaborate to Accelerate Life Sciences Cloud Development, from 4:41PM ET on Monday Apr 08, 2024 by MT Newswires

Peers Headlines

Today

Regeneron Faces Q1 Seasonality Despite Eylea HD Launch, Oppenheimer Says, from 4 hours ago by MT Newswires

Guggenheim Adjusts Price Target on Biogen to $255 From $275, from 5 hours ago by MT Newswires

--UBS Adjusts ICON Price Target to $380 From $368, Maintains Buy Rating, from 6 hours ago by MT Newswires

Oppenheimer Adjusts Price Target on Regeneron Pharmaceuticals to $1,175 From $1,125, from 8 hours ago by MT Newswires

Yesterday

--Goldman Sachs Adjusts Biogen Price Target to $340 From $393, from 8:18AM ET on Thursday Apr 25, 2024 by MT Newswires

--Canaccord Genuity Adjusts Price Target on Biogen to $308 From $305, from 8:03AM ET on Thursday Apr 25, 2024 by MT Newswires

--Barclays Adjusts Price Target on Biogen to $200 From $215, from 8:02AM ET on Thursday Apr 25, 2024 by MT Newswires

--HC Wainwright Adjusts Biogen's Price Target to $300 From $325, from 7:39AM ET on Thursday Apr 25, 2024 by MT Newswires

--Wedbush Adjusts Price Target on Biogen to $215 From $213, from 6:48AM ET on Thursday Apr 25, 2024 by MT Newswires

Apr 24, 2024

ICON Q1 Adjusted EPS, Revenue Rise, 2024 Guidance Range Narrowed, from 4:55PM ET on Wednesday Apr 24, 2024 by MT Newswires